An In-Depth Understanding of the Chinese Pharmaceutical Industry

News provided by

Oct 01, 2013, 06:51 ET

MUMBAI, October 1, 2013 /PRNewswire/ --

Bharat Book Bureau Presents Pharmaceutical Industry China - Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges. ( http://www.bharatbook.com/healthcare-market-research-reports/pharmaceutical-industry-china.html )

(Logo: http://photos.prnewswire.com/prnh/20130128/590935 )

It is a comprehensive report on the pharmaceutical and biotechnology industry in China and its impact on international markets. This report tackles not only global pharmaceutical company interest in China but also home grown companies and their battle for position. The business environment in which they compete is analyzed as are key drivers, constraints, challenges and opportunities.

A wealth of financial information is provided including:

Company financials, sales & revenue figures - historical to Q2•2013
China GDP, economic growth, export (bulk drug, formulations) figures
Indian health expenditure as a function of GDP
Growth change figures of emerging and developing countries (India, Russia, China, Brazil)
Economic growth figures of advanced economies (USA, UK, Germany, France, Italy, Spain, Japan, Canada)
Projected figures of strategic emerging industry GDP percentage contribution

SWOT, Economic and Business Environment specifics include:

Key strengths, weaknesses and threats influencing leading player position within the market
Top Five Contract Pharmaceutical Export Markets of China
Major players within China's leading therapeutic markets (e.g., cancer, allergy, liver disease)
Multinational penetration into the Chinese Pharma Market
Comprehensive product portfolios, R&D activity and pipeline therapeutics
M&A activity and future strategies of top Chinese pharmacos
Economic indicators, trade policy, merchandise and commercial trade statistics
Gross Domestic Product of China, historic and projection analysis
Chinese economic outlook in comparison to advanced economies
Three Tier 'Pharmerging' Markets with Potential for Significant Growth
Prescription drug sales distribution channels in China
Major Biogeneric products in China

The Chinese biopharmaceutical market is presented as follows:

By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS)
By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression)

What you will gain:

An in-depth understanding of the Chinese biopharmaceutical market and it's environment
Current market facts, figures and product lines of key players in the industry
An insight into how generic therapeutics will propagate the Chinese biopharmaceutical market
Knowledge of how the Chinese pharma market will integrate into the global healthcare market
Information on key regulatory and government policies
Data on levels of private and publically funded biopharma studies in China
Strategies on how to adapt and restructure current business models to this industry

Key concerns to the Chinese biopharmaceutical market such as:

Lack of regulatory policy and legislation
Reimbursement schemes and payers concerns
Funding and government sponsorship issues
International scepticism of Chinese safety and efficacy therapeutic profiles

This report will tell you if the companies mentioned are:

Strong, competitive players
Pooling their resources for specific growth and therapeutic areas
Investing strategically in R&D
Have a history of strategic M&A activity

Covers significant Chinese and multinational pharmacos and gives details of their operations, products, financials and business strategy:

Amoytop Biotech
Active Pharmaceutical Products
Beijing Continent Pharmaceuticals
FusoGen Pharmaceuticals
Shanghai Huaguan Biochip
SiBiono GeneTech
Abbott
AstraZeneca
Boehringer Ingelheim
Eli Lilly
GlaxoSmithKline
Johnson & Johnson Medical
Merck
Novartis
Pfizer
Roche

Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=408064

For more information on the report: http://www.bharatbook.com/healthcare-market-research-reports/pharmaceutical-industry-china.html

Related Reports:

Related Category:

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:
Poonam
Bharat Book Bureau
UK: +44 7405 208461
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Skype - bharatbook
E-mail: [email protected]
Website: http://www.bharatbook.com
Live Chat - http://bit.ly/19m3TU4